It has been shown, both functionally and by peptide-HLA crystal structure determination, that citrullinated peptides are preferentially presented by RA-associated HLA-DRB1 risk alleles [64,197]. The gene discussed is HLA-DRB1; the disease is rheumatoid arthritis.